Browsing by Author "Nedeljkovic Beleslin, Biljana (6701355427)"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Cardiovascular Imaging for Coronary Artery Disease in Patients with Diabetes Mellitus(2024) ;Nedeljkovic Beleslin, Biljana (6701355427) ;Al Nooryani, Arif (23494752600)Beleslin, Branko (6701355424)In patients with diabetes mellitus, accelerated progression of atherosclerosis can lead to worse clinical outcomes. Determining the best diagnostic strategy to identify patients with increased cardiovascular risk is challenging. Current guidelines recommend using both functional imaging and CT angiography to detect myocardial ischemia and coronary artery disease based on pre-test probability. Functional imaging is suggested for patients with a higher clinical likelihood due to its higher rule-in diagnostic capacity. On the other hand, CT angiography is preferred for patients with lower pre-test probability because of its excellent negative predictive value. The optimal management strategy for asymptomatic diabetic patients remains unclear. In asymptomatic diabetic patients, previous randomized trials have not shown benefits from diagnostic testing over standard care. However, these trials were methodologically inconsistent and lacked clear stratification of cardiovascular risk. In terms of invasive evaluation, a combined invasive functional and anatomic imaging approach for angiographically intermediate coronary stenosis appears to be the best, most effective decision pathway for managing diabetic patients. © 2024 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication Comparison of efficacy and safety of parenteral versus parenteral and oral glucocorticoid therapy in Graves’ orbitopathy(2020) ;Nedeljkovic Beleslin, Biljana (6701355427) ;Ciric, Jasmina (6601995819) ;Stojkovic, Mirjana (7006722691) ;Savic, Slavica (35328081800) ;Lalic, Tijana (57189371865) ;Stojanovic, Milos (58202803500) ;Miletic, Marija (57218320927) ;Knezevic, Miroslav (36192212000) ;Stankovic, Branislav (16205536900)Zarkovic, Milos (7003498546)Background/Aims: The most effective and safe treatment protocol for Graves’ orbitopathy (GO) needs to be further assessed. The aim of the present study was to evaluate the efficacy, safety and outcome of parenteral versus parenteral and oral glucocorticoid (GC) protocols in euthyroid patients with untreated and active moderate to severe GO. Methods: This was a retrospective observational study in 140 patients comparing intravenous GC pulses only (IVGC group, 74 patients, 51 ± 11 years) with historical controls of combined oral and intravenous GC therapy (CombGC group, 66 patients, 49 ± 10 years, P = ns). IVGC therapy included infusions of 500 mg of methylprednisolone weekly for the first six weeks, followed by infusions of 250 mg weekly for the remaining six weeks (cumulative dose 4.5 g). CombGC therapy included 500 mg of methylprednisolone in 500 mL of saline solution for two alternative days, followed by oral prednisone tapering dose repeated each month for the next 5 months (cumulative dose 10.2 g). Results: The overall success of the treatment was 43/66 (65%) in the CombGC group and 37/73 (51%, P =.071) in the IVGC group. Deterioration of GO developed in four (6%) patients during CombGC therapy and in nine (12%, P =.214) patients during IVGC therapy. After 6 months, relapse of GO was observed in 10/37 (26%) in the IVGC group, whereas none of the patients in CombGC had a relapse (P <.001). There were significantly more side effects in the CombGC versus IVGC group (49/66, 74% vs 28/74, 38%, P <.001). Conclusions: Our data suggest that CombGC therapy was more efficient with significantly less relapse rate, but with more side effects in comparison to IVGC therapy. © 2020 John Wiley & Sons Ltd - Some of the metrics are blocked by yourconsent settings
Publication Impairment of Left Ventricular Function in Hyperthyroidism Caused by Graves’ Disease: An Echocardiographic Study(2024) ;Petrovic Djordjevic, Ivana (57815873500) ;Petrovic, Jelena (57207943674) ;Radomirovic, Marija (58483860800) ;Petrovic, Sonja (59678402300) ;Biorac, Bojana (59677714600) ;Jemuovic, Zvezdana (57195299822) ;Tesic, Milorad (36197477200) ;Trifunovic Zamaklar, Danijela (9241771000) ;Nedeljkovic, Ivana (55927577700) ;Nedeljkovic Beleslin, Biljana (6701355427) ;Simic, Dragan (57212512386) ;Zarkovic, Milos (7003498546)Vujisic-Tesic, Bosiljka (6508177183)Background/Objectives: The thyroid gland has an important influence on the heart. Long-term exposure to high levels of thyroid hormones may lead to cardiac hypertrophy and dysfunction. The aim of the study was to evaluate the morphological and functional changes in the left ventricle in patients with hyperthyroidism caused by Graves’ disease (GD) in comparison with healthy individuals, as well as to investigate potential differences in these parameters in GD patients in relation to the presence of orbitopathy. Methods: The prospective study included 39 patients with clinical manifestations and laboratory confirmation of GD and 35 healthy controls. All participants underwent a detailed echocardiographic examination. The groups were compared according to demographic characteristics (age and gender), heart rate and echocardiographic characteristics. Results: The patients with hyperthyroidism caused by GD had significantly higher values of left ventricular diameter, left ventricular volume and left ventricular mass compared to the healthy controls. In addition, hyperthyroidism significantly influenced the left ventricular contractility and led to the deterioration of the systolic and diastolic function, as shown together by longitudinal strain, color Doppler and tissue Doppler imaging. However, the patients with GD and orbitopathy showed better left ventricular function than those without orbitopathy. Conclusions: Besides the confirmation of previously known findings, our study indicates possible differences in echocardiographic parameters in GD patients in relation to the presence of orbitopathy. Further investigation with larger samples and meta-analyses of data focused on the evaluation of echocardiographic findings in the context of detailed biochemical and molecular analyses is required to confirm our preliminary results and their clinical significance. © 2024 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication The Coronary ARteriogenesis with combined Heparin and EXercise therapy in chronic refractory Angina (CARHEXA) trial: A double-blind, randomized, placebo-controlled stress echocardiographic study(2021) ;Petrovic, Marija T (57207720679) ;Djordjevic-Dikic, Ana (57003143600) ;Giga, Vojislav (55924460200) ;Boskovic, Nikola (6508290354) ;Vukcevic, Vladan (15741934700) ;Cvetic, Vladimir (57189236266) ;Mladenovic, Ana (57208748922) ;Radmili, Oliver (36125483800) ;Markovic, Zeljko (53264278700) ;Dobric, Milan (23484928600) ;Aleksandric, Srdjan (35274271700) ;Tesic, Milorad (36197477200) ;Juricic, Stefan (57203033137) ;Nedeljkovic Beleslin, Biljana (6701355427) ;Stojkovic, Sinisa (6603759580) ;Ostojic, Miodrag C (34572650500) ;Beleslin, Branko (6701355424)Picano, Eugenio (7102408994)Background: Coronary collateral circulation exerts protective effects on myocardial ischaemia due to coronary artery disease and can be promoted by exercise with heparin co-administration. Whether this arteriogenetic effect is accompanied by functional improvement of left ventricle during stress and lessening of angina symptoms remains unknown. Aims: To evaluate the anti-ischaemic efficacy of heparin plus exercise in coronary artery disease. Methods: In a prospective, single-centre, randomized, double-blind study we recruited 32 'no-option' patients (27 males; mean age 61 ± 8 years) with stable angina, exercise-induced ischaemia and coronary artery disease not suitable for revascularization. All underwent a two-week cycle of exercise (two exercise sessions per day, five days per week) and were randomized (n = 16 per group) to intravenous placebo (0.9% saline) versus unfractionated heparin (5.000 IU intravenously), 10 min prior to exercise. We assessed Canadian Cardiovascular Society angina class, stress electrocardiogram and echo parameters (wall motion score index) and computed tomography angiography for collaterals. Results: After two-week cycle, Canadian Cardiovascular Society class statistically decreased in both groups (heparin plus exercise group: 2.6 ± 0.7 to 1.9 ± 0.7, p < 0.001, exercise group: 2.4 ± 0.7 to 2.1 ± 0.9, p = 0.046). Only the heparin plus exercise group improved time-to-ST segment depression (before 270, 228-327 s vs. after 339, 280-360 s, p = 0.012) and wall motion score index (before 1.38 ± 0.25 vs. after 1.28 ± 0.18, p = 0.005). By multi-slice computed tomography angiography, collaterals improved in 12/15 (80%) in the heparin plus exercise group versus 2/16 (12.5%) in the exercise group (p < 0.001). Conclusion: A two-week, 10-test cycle of heparin plus exercise is better than exercise in improving angina class, myocardial ischaemia and collaterals by computed tomography angiography. © 2020 Published on behalf of the European Society of Cardiology. All rights reserved.
